Searchable abstracts of presentations at key conferences in endocrinology

ea0011p72 | Clinical case reports | ECE2006

Regression of somatotropinoma in the course of treatment with octreotide in a female patient with acromegaly

Matuszek B , Lenart-Lipiska M , Nowakowski A

Long-acting somatostatin analogs are now increasingly being prescribed as adjuvant and primary therapy for the treatment of acromegaly. Many studies have shown them to be both effective and safe, by suppressing GH levels and normalizing serum IGF-1 levels in most cases.The aim of the study was to analyze the case report of a female patient with active acromegaly and evaluate the efficacy of long-acting synthetic analog of somatostatin (Sandostatin LAR) for biochemical control ...

ea0011p369 | Diabetes, metabolism and cardiovascular | ECE2006

The metabolic control levels of 548 diabetic outpatients compared with the current guidelines of Polish Diabetes Association (PDA)

Malicka J , Kurowska M , Tarach JS , Nowakowski A

The current PDA recommendations relating to the good metabolic control of diabetes are: self-controlled fasting blood glucose (FBG)70–90 mg%, HbA1c ≤6.1%, lipid profile (LP) TChol ≤175 mg%, LDL≤100 mg%, HDL ≥40 mg%, TG≤150 mg%.Objective: To evaluate the accomplishment of the proper metabolic control in diabetic outpatients with regard to the PDA guidelines.Material and Methods: a548 diabetics (249...

ea0011p452 | Endocrine tumours and neoplasia | ECE2006

A typical clinical picture of four insulinoma cases

Kurowska M , Malicka J , Tarach JS , Nowakowski A

Introduction: Insulinomas are usually singular adenomas <1 cm. Less than 5% have diameter >3 cm. Multiple adenomas frequency is estimated on 3 do 9%. Malignant insulinomas are diagnosed in 3–6% patients. The oldest patient with insulinoma described in literature was 95 years old. About 30–50% of patients are previously misdiagnosed.Aim of the study: The aim of the study was presentation of patients with rare clinical characteristics of ...

ea0011p582 | Neuroendocrinology and behaviour | ECE2006

Hypopituitary patients have a high occurrence of metabolic syndrome markers and an increased prevalence of cardiovascular risk factors

Matuszek B , Obel E , Kowalczyk M , Nowakowski A

Introduction: Hypopituitary patients receiving conventional hormone substitution, but without GH replacement, have an increased mortality from cardiovascular diseases. Inadequate hormone replacement is a possible cause of this increased mortality. GH deficiency in adult patients has been associated with several cardiovascular risk factors, including hyperlipidemia, increased abdominal adiposity, and impaired insulin sensitivity.Aim of the study: The aim ...

ea0029p592 | Diabetes | ICEECE2012

Comparative analysis of adiponectin isoforms distribution in pregnant women with gestational diabetes mellitus and after delivery

Matuszek B. , Burska A. , Leszczynska-Gorzelak B. , Donica H. , Nowakowski A.

Objective: The aim of the study was to evaluate distribution of circulating adiponectin (AdipoQ) isoforms at pregnant women with gestational diabetes mellitus (GDM) and comparison analysis of isoform distribution changes 12 months after delivery.Design: The study was conducted on 64 pregnant women who underwent routine pre-natal tests for GDM between 24 and 28 week of gestation and 30 of them 12 months after delivery. The study group included 36 women di...

ea0014p588 | (1) | ECE2007

Hypopituitary patients have an increased prevalence of cardiovascular risk factors

Matuszek Beata , Kowalczyk Mariusz , Zapolski Tomasz , Nowakowski Andrzej

Introduction: Hypopituitary patients receiving conventional hormone replacement, but without GH replacement, have an increased mortality from cardiovascular diseases. Inadequate hormone replacement is a possible cause of this increased mortality. GH deficiency in adult patients has been associated with several cardiovascular risk factors, including hyperlipidemia, increased abdominal adiposity, and impaired insulin sensitivity.The aim of the study is an ...

ea0011p281 | Diabetes, metabolism and cardiovascular | ECE2006

Myocardial ischemia in type 1 diabetic patients – re-examination after four years

Kowalczyk M , Chrapko B , Zaorska-Rajca J , Tarach JS , Nowakowski A

The silent myocardial ischemia is a serious diagnostic problem especially in patients with long-standing diabetes of type 1 (DM). Resting as well as exercise myocardial perfusion scintigraphy tests allow to recognize the silent myocardial ischemia in these groups of patients and to start the relevant treatment. The aim of the study was to establish the prevalence of myocardial ischemia in patients with type 1 DM, without clinical symptoms of ischemic heart disease (IHD) and wi...

ea0032p405 | Diabetes | ECE2013

Correlations between umbilical and maternal adiponectin as well as neonatal birthweight

Matyjaszek-Matuszek Beata , Burska Agata , Gernand Wojciech , Lenart-Lipinska Monika , Nowakowski Andrzej , Paszkowski Tomasz

Introduction: Adiponectin (AdipoQ) is a known insulinsensitizing adipokine which is also present in fetal circulation. It has been postulated to play a role in the regulation of fetal growth and development together with other adipokines. The aim of the study was to determine fetal adiponectin and find its correlations with the neonatal birthweight and maternal AdipoQ.Patients and methods: The study included 36 women with singleton pregnancy (20 diagnose...

ea0032p408 | Diabetes | ECE2013

Fibroblast growth factor 21: a new predictor of cardiovascular events in type 2 diabetes

Lenart-Lipinska Monika , Matyjaszek-Matuszek Beata , Gernand Wojciech , Solski Janusz , Nowakowski Andrzej

Introduction: The course of type 2 diabetes (DM2) is linked with increased fibroblast growth factor 21 (FGF21) concentrations, however little information is available on the prognostic significance of FGF21 in DM2. The aim of the study was to assess whether FGF21 may be a predictor of cardiovascular (CV) events in patients with DM2.Patients and methods: The study comprised 87 patients with DM2, aged 57–66 years, with the median duration of diabetes ...

ea0029p591 | Diabetes | ICEECE2012

Adiponectin among markers of low grade inflammation in gestational diabetes mellitus

Matuszek B. , Burska A. , Malecha-Jedraszek A. , Lenart-Lipinska M. , Nowakowski A. , Donica H.

Background and aims: The subclinical inflammation connected with hypoadiponectinaemia and inflammatory pattern may favor the development of gestational diabetes mellitus (GDM).Methods: In total, 66 pregnant women were enrolled in the study during systematic testing for GDM between 24 and 28 weeks of gestation. GDM was diagnosed in 42 cases, 24 were normal glucose tolerant control group (NGT). In blood serum concentration of glucose, insulin, adiponectin ...